Updating results

188 results

Sort: Relevance | Date

Workplace health: policy and management practices

Everything NICE has said on workplace policy and management practices to improve the health and wellbeing of employees in an interactive flowchart

NICE Pathway Published June 2015 Last updated November 2019

Dementia, disability and frailty in later life: mid-life approaches to delay or prevent onset

Everything NICE has said on preventing or delaying dementia, disability and frailty in an interactive flowchart

NICE Pathway Published October 2015 Last updated November 2019

Chronic fatigue syndrome myalgic encephalomyelitis

Everything NICE has said on assessing, diagnosing and managing chronic fatigue syndrome/myalgic encephalomyelitis in an interactive flowchart

NICE Pathway Published March 2014 Last updated November 2019

Sepsis

Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

NICE Pathway Published July 2016 Last updated January 2020

Acutely ill patients in hospital

Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart

NICE Pathway Published August 2012 Last updated January 2020

Liver conditions

Everything NICE has said on liver conditions in an interactive flowchart

NICE Pathway Published March 2014 Last updated January 2020

Non-alcoholic fatty liver disease

Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart

NICE Pathway Published July 2016 Last updated January 2020

Liver cancers

Everything NICE has said on liver and bile duct cancers in an interactive flowchart

NICE Pathway Published November 2013 Last updated January 2020

Cirrhosis

Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart

NICE Pathway Published July 2016 Last updated January 2020

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated January 2020

Air pollution

Everything NICE has said on improving air quality to prevent ill health in an interactive flowchart

NICE Pathway Published June 2017 Last updated January 2020

Rheumatoid arthritis

Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

NICE Pathway Published April 2013 Last updated January 2020

Influenza

Everything NICE has said on influenza in an interactive flowchart

NICE Pathway Published August 2018 Last updated January 2020

Chronic heart failure

Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated January 2020

Hepatitis B (chronic)

Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart

NICE Pathway Published June 2013 Last updated January 2020

Pneumonia

Everything NICE has said on diagnosing and managing community- and hospital-acquired pneumonia in an interactive flowchart

NICE Pathway Published December 2014 Last updated January 2020

Antimicrobial stewardship

Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart

NICE Pathway Published August 2015 Last updated January 2020

Advanced breast cancer

Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart

NICE Pathway Published May 2011 Last updated January 2020

Neutropenic sepsis

Everything NICE has said on preventing, identifying and managing neutropenic sepsis in children, young people and adults in an interactive flowchart

NICE Pathway Published September 2012 Last updated January 2020

Ovarian cancer

Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

NICE Pathway Published February 2012 Last updated January 2020

Self-limiting respiratory tract and ear infections – antibiotic prescribing

Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart

NICE Pathway Published August 2012 Last updated January 2020

Lung cancer

Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

NICE Pathway Published March 2012 Last updated January 2020

Prevention and control of healthcare-associated infections

Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart

NICE Pathway Published March 2012 Last updated January 2020

Supporting adult carers

Everything NICE has said on supporting adults carers in an interactive flowchart

NICE Pathway Published January 2020

How effective and cost effective are education-based alcohol interventions targeted at children and young people aged 11 to 25 with SEND who are thought to be vulnerable to alcohol misuse?

Recommendation ID NG135/4 Question How effective and cost effective are education-based alcohol interventions targeted at children and young

Research recommendation Published October 2019

How effective and cost effective are individual, compared with group, education-based interventions for children and young people aged 11 to 18 in full-time education who are thought to be vulnerable to alcohol misuse?

Recommendation ID NG135/2 Question How effective and cost effective are individual, compared with group, education-based interventions for

Research recommendation Published October 2019

What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate in the induction of remission in mild-to-moderate ulcerative colitis unresponsive to aminosalicylates?

Recommendation ID NG130/2 Question What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate

Research recommendation Published October 2019

What is the clinical and cost effectiveness of prednisolone, budesonide, and beclometasone in addition to aminosalicylates compared with each other and with aminosalicylate monotherapy for the induction of remission for people with mild-to-moderate ulcerative colitis?

Recommendation ID NG130/3 Question What is the clinical and cost effectiveness of prednisolone, budesonide, and beclometasone in addition

Research recommendation Published October 2019

How effective and cost effective are universal, education-based alcohol interventions for children and young people aged 11 to 25 with SEND?

Recommendation ID NG135/3 Question How effective and cost effective are universal, education-based alcohol interventions for children and

Research recommendation Published October 2019

What components of alcohol education delivery contribute to its effectiveness for children and young people aged 11 to 18 in full-time education, and those with special educational needs and disabilities (SEND) up to the age of 25?

Recommendation ID NG135/1 Question What components of alcohol education delivery contribute to its effectiveness for children and young

Research recommendation Published October 2019

The committee recommended further research to determine if using the lead‑I electrocardiogram (ECG) devices in primary care for people with signs or symptoms of atrial fibrillation, and an irregular pulse, increases the number of people with atrial fibrillation (including paroxysmal) detected, ompared with current practice (that is, a 12‑lead ECG done later). The committee considered the feasibility of collecting data to see if using the lead‑I ECG devices increased the detection of atrial fibrillation that would be missed if only 12‑lead ECGs done later were available. It noted that even if a lead‑I ECG is used and atrial fibrillation is detected, a subsequent 12‑lead ECG would still be done to check for structural cardiac abnormalities and inform further management decisions. The committee concluded that practices using lead‑I ECG devices could determine the number of additional cases of atrial fibrillation detected by the devices. This can be done by identifying people with a confirmed positive lead‑I ECG for atrial fibrillation who subsequently had a 12‑lead ECG that was negative because the atrial fibrillation had stopped. The committee also considered that data collected on the time between the initial lead‑I ECG and the subsequent 12‑lead ECG would be useful.

Recommendation ID DG35/1 Question The committee recommended further research to determine if using the lead‑I electrocardiogram (ECG) devices

Research recommendation Published October 2019

What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in the post-surgical period of Crohn's disease?

Recommendation ID NG129/1 Question What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in the

Research recommendation Published October 2019

What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction of remission for people with moderate ulcerative colitis?

Recommendation ID NG130/4 Question What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction

Research recommendation Published October 2019

What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone plus an aminosalicylate for induction of remission for people with moderate ulcerative colitis?

Recommendation ID NG130/5 Question What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone

Research recommendation Published October 2019

What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab and infliximab compared with each other and with placebo for induction of remission for people with subacute ulcerative colitis that is refractory to systemic corticosteroids?

Recommendation ID NG130/6 Question What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab

Research recommendation Published October 2019

Secondary research is recommended to understand the comparative performance of different ELISA tests for therapeutic monitoring of tumour necrosis factor (TNF)‑alpha inhibitors in rheumatoid arthritis

Recommendation ID DG36/3 Question Secondary research is recommended to understand the comparative performance of different ELISA tests for

Research recommendation Published October 2019

What is the utility of routine cardiovascular evaluation for asymptomatic people with FH?

Recommendation ID CG71/6 Question What is the utility of routine cardiovascular evaluation for asymptomatic people with FH? Any explanatory

Research recommendation Published November 2019

When is it safe to stop contact casting in the treatment of acute Charcot arthropathy?

Recommendation ID NG19/12 Question When is it safe to stop contact casting in the treatment of acute Charcot arthropathy? Any explanatory

Research recommendation Published November 2019

Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy?

Recommendation ID NG19/11 Question Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy? Any

Research recommendation Published November 2019

What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula‑fed infants with frequent regurgitation associated with marked distress?

Recommendation ID NG1/2 Question What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula‑fed infants

Research recommendation Published November 2019